Welcome Customer !

Membership

Help

Beijing Bored Technology Development Co., Ltd
Custom manufacturer

Main Products:

instrumentb2b>Products
Product Categories

Beijing Bored Technology Development Co., Ltd

  • E-mail

  • Phone

  • Address

    B1, 9th Floor, Yangming Plaza, Xiaoying Road, Chaoyang District, Beijing

Contact Now

Induction of acute pancreatitis model by Ceruletide

NegotiableUpdate on 05/06
Model
Nature of the Manufacturer
Producers
Product Category
Place of Origin

Overview

Caerulein is a gastric regulatory molecule similar in function and composition to cholecystokinin (CCK), induced by Ceruletide in acute pancreatitis model.

Product Details

雨蛙素(Ceruletide)急性胰腺炎模型诱导

caeruleinCeruletide)Animal disease model induced acute pancreatitis

Introduction:

acute pancreatitis(Acute pancreatitis, AP)It is a common acute abdomen in clinical practice, with complex causes and a mortality rate of up to5%~10%Severe illnessAPThe mortality rate is as high as20%~30%At present, the pathogenesis has not been elucidated and there is no specific treatment method. Currently liveAPThe commonly used methods for animal model production include pancreatic duct ligation, duodenal loop closure, pancreatic duct puncture injection, pancreatic submucosal injection, pancreatic duct injection combined with intravenous infusion, and intraperitoneal injection of frog skin extract and lipopolysaccharide.

caerulein(Caerulein)It is a substance similar in function and composition to cholecystokinin(cholecystokininCCK)Gastric regulatory molecules stimulate excessive secretion of pancreatic acinar cells, leading to obstacles in the separation of trypsinogen and lysosomal hydrolases within the cells. Through the use of tissue proteasesBActivation occurs in a dependent manner, and the activity of pancreatic enzymes can further lead to the activation of zymogens, causing a series of cell damage caused by protease activity. The inflammatory response caused by self digestion of pancreatic tissue recruits inflammatory cells, releases inflammatory factors, and further causes severe local or even systemic inflammatory reactions.

Operation process:

1. select6Zhou Ling's masculinityC57BL/6Mice, raised inSPFLevel environment, maintain12Hour light dark cycle, temperature 20Humidity40%-60%Free to eat and drink.

2. Implementation of mold making

1Animal pretreatment

Before modeling8Fasting treatment (without water) was performed on mice at an hour to reduce the interference of gastrointestinal contents on pancreatic detection.

2Preparation of rain frog extract

Dilute rain frog extract with physiological saline to the working concentration.

3)Intraperitoneal injection

press100ug/kgDose of weight, per1Inject intraperitoneally into mice at an hour1Secondary rain frog hormone, continuous injection8Multiple low-dose injections can simulate the progressive onset of acute pancreatitis in humans, avoiding acute mortality caused by a single high-dose injection.

4)blank control

The control group mice were intraperitoneally injected with an equal amount of physiological saline at the same time to eliminate the stress effects of the injection procedure itself.

5)Observation and sample collection after modeling

After modeling, closely observe the mental state, activity level, food and water intake, and fecal characteristics of the mice to evaluate their overall stress response. Injecting rain frog hormone24After hours, euthanize the mice and collect key samples:

a.pancreatic tissue

Quickly separate the pancreas, weigh and partially fix it in place10%Neutral formalin (used for pathological sections), partially frozen in liquid nitrogen (used for molecular detection).

b.blood sample

After collecting blood from the eye socket, centrifuge and separate the serum for detecting amylase, lipase, and inflammatory factors.

c.Other samples

According to research needs, samples such as colon and feces can be collected for correlation analysis.

3.Model validation:

1)Pathological injury of pancreatic tissue

a.throughHEStaining was used to observe the morphological changes of the pancreas, and the model group showed structural disorder, edema, and necrosis of pancreatic acinar cells, as well as infiltration of a large number of inflammatory cells.

b.Model group pancreas/An increase in body weight indicates pancreatic swelling and injury.

2)Elevated levels of serum digestive enzymes

The serum amylase and lipase activities in the model group were significantly higher than those in the blank control group, and the difference was statistically significant(p<0.0001)Confirmed that damage to pancreatic acinar cells leads to the release of digestive enzymes into the bloodstream.

3)Release of serum pro-inflammatory cytokines

Model group serum pro-inflammatory factorsIL-6TheTNF-The significant increase in alpha concentration indicates that rain frog extract successfully induced systemic spread of pancreatitis.

Product Information

brand

Item Number

CASnumber

Product Name

specification

APExBio

B8465

17650-98-5

Ceruletide (caerulein)

5mg/10mg

Related products:

APExBIOProvide small molecule compounds related to modeling various diseases, including but not limited to tumors, metabolic diseases, neurodegenerative diseases, cardiovascular diseases, etc.

Item Number

CAS

Product Name

application

A1042

4474-91-3

AngiotensinII(angiotensinII)

Hypertension modeling

A7088

51298-62-5

L-NAME hydrochloride

Hypertension modeling

A1042

4474-91-3

Angiotensin II (angiotensinII)

Hypertension modeling

A7088

51298-62-5

L-NAME hydrochloride

Hypertension modeling

A8486

59-87-0

Nitrofurazone

Breast tumor modeling

A8321

15663-27-1

Cisplatin (cisplatin)

Modeling of acute renal failure

A4540

78111-17-8

Okadaic acid

Skin cancer modeling

B8205

9011-18-1

Dextran sulfate sodium salt

(MW 35000-45000)

Colorectal cancer modeling

BA3958

55-18-5

N-Nitrosodiethylamine (Diethylnitrosamine)

Liver tumor modeling

B1922

59865-13-3

Cyclosporin A (CyclosporineA)

Modeling of urinary system diseases

C6417

1404-90-6

Vancomycin (vancomycin)

Modeling of urinary system diseases

B8352

51-79-6

Urethane

Lung cancer modeling

A8331

9041-93-4

Bleomycin Sulfate

Pulmonary fibrosis modeling

B1389

19774-82-4

Amiodarone HCl

Pulmonary fibrosis modeling

BA7410

9006-59-1

Ovalbumins

Modeling of Allergic Asthma

A3634

23007-85-4

MPTP hydrochloride

Parkinson's disease modeling

B7099

636-00-0

6-Hydroxydopamine hydrobromide

Parkinson's disease modeling

B5462

83-79-4

Rotenone (rotenone)

Parkinson's disease modeling

B6226

487-79-6

Kainic acid

Epilepsy modeling

N1592

485-49-4

(-)-Bicuculline

Epilepsy modeling

B7005

363-24-6

Prostaglandin E2

Pathological pain modeling

A8896

77086-22-7

(+)-MK 801 Maleate

Modeling of schizophrenia

A1039

131602-53-4

Amyloid Beta-peptide (25-35) (human)

Alzheimer's disease modeling

B6057

107761-42-2

AmyloidB-Peptide (1-42) (human)

Alzheimer's disease modeling

A2324

1950/2/2

Dexamethasone (DHAP)

Modeling of neurological related diseases

N1871

56-69-9

5-HTP

Modeling of neurological related diseases

A8306

149635-73-4

MOG (35-55)

Modeling of autoimmune encephalomyelitis

C4223

506-32-1

Arachidonic Acid (arachidonic acid)

Modeling of autoimmune encephalomyelitis

N2060

16561-29-8

PMA (phorbol ester)

Modeling of immune and inflammatory diseases

A1832

25316-40-9

Doxorubicin HCl (Doxorubicin hydrochloride)

Modeling of immune and inflammatory diseases

A2515

31282-04-9

Hygromycin B (HygromycinB)

Modeling of immune and inflammatory diseases

B1054

144875-48-9

Resiquimod (R-848)

Myocarditis modeling

A4013

50-78-2

Aspirin (acetylsalicylic acid)

Gastrointestinal ulcer modeling

A8449

53-86-1

Indomethacin

Gastrointestinal ulcer modeling

B8465

17650-98-5

Ceruletide (caerulein)

Pancreatitis modeling

C8628

81-24-3

Taurocholic acid

Pancreatitis modeling

C6435

74-79-3

L-Arginine

Pancreatitis modeling

A2343

50-18-0

Cyclophosphamide

Cystitis modeling

B2065

67-97-0

Vitamin D3 (vitaminD3)

Kidney stone modeling

A5161

99011-02-6

Imiquimod

Psoriasis modeling

A4457

18883-66-4

Streptozotocin (STZ,Streptozotocin)

Diabetes modeling

A4052

24390-14-5

Doxycycline hyclate (Oxytetracycline hydrochloride)

Constructing a gene expression regulation model

B1394

54965-24-1

Tamoxifen Citrate (Tamoxifen citrate)

Constructing a gene expression regulation model

B3677

58-63-9

Inosine (Inosine)

Hyperuricemia modeling

B1468

73-24-5

Adenine (adenine)

Hyperuricemia modeling

B1702

Cholesterol

Cholesterol (cholesterol)

Modeling of hyperlipidemia

M1199

59-23-4

Galactose

Aging modeling

C3481

1184-78-7

Trimethylamine N-oxide

Modeling of heart disease

A3966

23214-92-8

Doxorubicin

Modeling of heart disease

For more animal model related products, please consult Beijing Bored Biotechnology Co., Ltd